Evidence map›Paper›PMID 31817033›Full record

ArticlePharmaceutics2019

PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis.

Patricia García-García, Ricardo Reyes, Elisabet Segredo-Morales, Edgar Pérez-Herrero, Araceli Delgado, Carmen Évora

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. In and outside the spotlight: Nanomedicine in the treatment of osteoporosis.The Journal of international medical research · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. A review on lipid and polymeric nano-based 17-β-estradiol delivery systems: advances and challenges.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Patricia García-GarcíaDepartment of Chemical Engineering and Pharmaceutical Technology, University of La Laguna, 38206 La Laguna, Spain.
Ricardo ReyesInstitute of Biomedical Technologies (ITB), University of La Laguna, 38206 La Laguna, Spain.
Elisabet Segredo-MoralesDepartment of Chemical Engineering and Pharmaceutical Technology, University of La Laguna, 38206 La Laguna, Spain.
Edgar Pérez-HerreroDepartment of Chemical Engineering and Pharmaceutical Technology, University of La Laguna, 38206 La Laguna, Spain.
Araceli DelgadoDepartment of Chemical Engineering and Pharmaceutical Technology, University of La Laguna, 38206 La Laguna, Spain.
Carmen ÉvoraDepartment of Chemical Engineering and Pharmaceutical Technology, University of La Laguna, 38206 La Laguna, Spain.
Universidad de La Laguna · ES

Funding

Ministerio de Ciencia, Innovación y Universidades MAT2014-55657-R
6 · The paper itself

Abstract

The controlled release of active substances-bone morphogenetic protein 2 (BMP-2) and 17β-estradiol-is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system formed by a hydrogel core composed of chitosan (CHT) collagen, 2-hidroxipropil γ-ciclodextrin (HP-γ-CD), nanoparticles of hydroxyapatite (nano-HAP), and an electrospun mesh shell prepared with two external electrospinning films for the regeneration of a critical bone defect in osteoporotic rats. Microspheres were made with poly-lactide-

Indexed as

17-βestradiol releaseBMP-2-microspheresbone regenerationhydrogel systemosteoporosispolylactic acidpoly-lactide-co-glycolide

Identifiers

PMID31817033
PMCPMC6956377
OpenAlexW2993063409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.